Search

everythinglearnresearchcommunity

for

Search:↓

A simple scalp scraping can effectively distinguish fibrosing alopecia from androgenetic alopecia with seborrheic dermatitis.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Raman spectroscopy can identify finasteride polymorphs in tablets.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Method accurately measures finasteride and tamsulosin in combined drug form.

Finasteride may cause cataracts and floppy-iris syndrome.

The PRF/micrograft spray-on skin method effectively healed massive and chronic burns quickly.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

RADA16 is a promising material for tissue repair and regenerative medicine but needs improvement in strength and cost.

Best results found using acetonitrile, water, and trifluoroacetic acid or methanol mixture.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

PRPF is a safer and more effective treatment for hair loss than PRP.

Exprecell™ is as effective as traditional methods but produces more f-PRF and is simpler to use.

More research needed to confirm finasteride as standard treatment for FFA.

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.